Tag: depemokimab

Stock

FDA reviews GSK’s depemokimab for asthma, CRSwNP; decision due Dec. 16

03/03/2025
admin

FDA reviews GSK’s depemokimab for asthma, CRSwNP; decision due Dec. 16#FDA #reviews #GSKs #depemokimab #asthma #CRSwNP…